Mcl-1 and Bcl-x(L) coordinately regulate megakaryocyte survival

Blood. 2012 Jun 14;119(24):5850-8. doi: 10.1182/blood-2011-12-398834. Epub 2012 Feb 28.

Abstract

Mature megakaryocytes depend on the function of Bcl-x(L), a member of the Bcl-2 family of prosurvival proteins, to proceed safely through the process of platelet shedding. Despite this, loss of Bcl-x(L) does not prevent the growth and maturation of megakaryocytes, suggesting redundancy with other prosurvival proteins. We therefore generated mice with a megakaryocyte-specific deletion of Mcl-1, which is known to be expressed in megakaryocytes. Megakaryopoiesis, platelet production, and platelet lifespan were unperturbed in Mcl-1(Pf4Δ/Pf4Δ) animals. However, treatment with ABT-737, a BH3 mimetic compound that inhibits the prosurvival proteins Bcl-2, Bcl-x(L), and Bcl-w resulted in the complete ablation of megakaryocytes and platelets. Genetic deletion of both Mcl-1 and Bcl-x(L) in megakaryocytes resulted in preweaning lethality. Megakaryopoiesis in Bcl-x(Pf4Δ/Pf4Δ) Mcl-1(Pf4Δ/Pf4Δ) embryos was severely compromised, and these animals exhibited ectopic bleeding. Our studies indicate that the combination of Bcl-x(L) and Mcl-1 is essential for the viability of the megakaryocyte lineage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Biphenyl Compounds / administration & dosage
  • Biphenyl Compounds / pharmacology
  • Blood Cell Count
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Blood Platelets / pathology
  • Cell Count
  • Cell Death / drug effects
  • Cell Size
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian / drug effects
  • Embryo, Mammalian / pathology
  • Fetus / drug effects
  • Fetus / metabolism
  • Fetus / pathology
  • Gene Deletion
  • Hemorrhage / pathology
  • Liver / drug effects
  • Liver / embryology
  • Liver / metabolism
  • Liver / pathology
  • Lymphatic Vessels / drug effects
  • Lymphatic Vessels / pathology
  • Megakaryocytes / drug effects
  • Megakaryocytes / metabolism*
  • Megakaryocytes / pathology*
  • Megakaryocytes / ultrastructure
  • Mice
  • Mice, Inbred C57BL
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Nitrophenols / administration & dosage
  • Nitrophenols / pharmacology
  • Organ Specificity / drug effects
  • Piperazines / administration & dosage
  • Piperazines / pharmacology
  • Proto-Oncogene Proteins c-bcl-2 / deficiency
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Sulfonamides / administration & dosage
  • Sulfonamides / pharmacology
  • Thrombopoiesis / drug effects
  • bcl-X Protein / metabolism*

Substances

  • ABT-737
  • Biphenyl Compounds
  • Mcl1 protein, mouse
  • Myeloid Cell Leukemia Sequence 1 Protein
  • Nitrophenols
  • Piperazines
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides
  • bcl-X Protein